Resources

Robust policy is critical to achieving improved health outcomes—but far too often, action stops once a policy is developed and adopted. Policies are only as effective as the extent to which they are implemented, and poor policy implementation holds back efforts to expand equitable access to health services. To translate goals into meaningful outcomes, every policy needs a plan of action, resources, dissemination, and adaptation. That is why PATH, supported by the Bill & Melinda Gates Foundation, launched the Capital to Clinic (C2C) initiative to examine bottlenecks to policy implementation and create tools to help advocates usher policies from development in national capitals to implementation in local clinics.This resource, the culmination of the C2C initiative, looks across the policy cycle—from agenda setting and policy development to implementation and evaluation—and outlines actions that advocates can take to support the roles of decision-makers, hold them accountable, and act as a liaison between civil society, health providers, subnational stakeholders, and communities.Also included is a one-page infographic summary of the tool—a quick reference sheet ready to be posted on cubicle walls, bulletin boards, and/or social media.

Robust policy is critical to achieving improved health outcomes—but far too often, action stops once a policy is developed and adopted. Policies are only as effective as the extent to which they are implemented, and poor policy implementation holds back efforts to expand equitable access to health services. To translate goals into meaningful outcomes, every policy needs a plan of action, resources, dissemination, and adaptation. That is why PATH, supported by the Bill & Melinda Gates Foundation, launched the Capital to Clinic (C2C) initiative to examine bottlenecks to policy implementation and create tools to help advocates usher policies from development in national capitals to implementation in local clinics.This white paper, a key output of the C2C initiative, is informed by key takeaways from consultations with policymakers and advocates as well as the literature on policy implementation science. It seeks to better understand policy implementation by outlining existing frameworks from the literature and examining facilitators and barriers to policy implementation in two case studies—the Community-based Health Planning and Services (CHPS) policy in Ghana and the Community Health Extension Program (HEP) in Ethiopia.

This landscape of respiratory care equipment distributors across sub-Saharan Africa is intended to provide market insights into distributors in the region who can provide quality products and after-sales support. The distributors represented in this landscape were prioritized based on their geographic reach, quality assurance, and/or strong after-sales services. Each company completed a survey about their respective capabilities and engaged in follow-up discussions to further clarify their offerings. In this version (November 2021), products with stringent regulatory authority (SRA) approval were prioritized for inclusion. We will continue to build on this landscape as further engagement takes place.If your company supplies respiratory care equipment, has presence in sub-Saharan Africa, and would like to be considered for inclusion, please complete this short survey.

Middle-income countries not eligible for support from Gavi, the Vaccine Alliance, have been slow to introduce rotavirus vaccines, largely due to cost concerns. A PATH analysis shows that, in most cases, rotavirus vaccination is likely to be highly cost-effective and beneficial for these countries.Brief is available in English, French, Russian, and Spanish.

Medical oxygen has for too long been an afterthought among the competing priorities of global health. It is a World Health Organization essential medicine and necessary treatment for acute and chronic conditions alike, but inequitable access, production shortages, logistical failures, and a host of additional circumstances have inhibited the widespread adoption and consistent provision of this lifesaving resource.The COVID-19 pandemic has given added salience to the importance of medical oxygen and made stark the seriousness that a lack of access creates. As governments and health systems come to terms with the harsh realities that the pandemic has laid bare, and the resulting political capital and social engagement is mustered, there is a robust opportunity to make inroads against this inequity and help ensure that patients the world over can again breathe easy—in more ways than one.This supply intelligence brief series, Oxygen Generation and Storage, is intended to be a concise primer for decision-makers who govern, lead, support, or manage health systems and their associated facilities. Providing an overview of the key elements that define each technology—as well as key considerations related to COVID-19—it can establish a starting point for understanding the solutions available to meet a health system’s need for medical oxygen and its delivery. It should serve alongside a broader suite of planning and analytical requirements necessary for the implementation of medical oxygen solutions.